News

Nearly two-thirds of these leaders have already rolled out remote patient monitoring solutions across a range of critical ...
Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...
UK & Ireland, experts provided insights on market trends within the clinical trial industry and advice on engagement strategies.
Contingency management interventions for stimulant and opioid use disorders should offer $128 per week for vouchers or $55 ...
Healthcare mergers and acquisitions are in no short supply as providers, health tech companies, retailers and other industry ...
Under the new leadership of Marty Makary, the FDA should focus more attention on the critical role of real-world clinical data — such as from health insurance databases — in the ongoing assessment of ...
CRISPR Therapeutics could stage a comeback thanks to clinical and commercial progress. There are many promising corporations ...
As the pioneer of the industry's first Enterprise Clinical Data Management (eCDM™) platform, Q-Centrix integrates proprietary technology, the largest and most diverse team of clinical data ...
MRO Corp, which is backed by Parthenon, has acquired Q-Centrix Corp, a Chicago-based enterprise clinical data management platform. The seller was TPG Growth. No financial terms were disclosed.
We review use of artificial intelligence-based technologies in oncology clinical trials, with potential to improve patient recruitment and stratification, trial design and operations, and data mana ...
Why private equity firms are investing in clinical trial management systems Nordic Capital and Riverside see investment opportunities in interoperability, automation and compliance software for ...